Selected research
Industry Research
Full Blood Count (FBC) Test Industry Research Report 2026
Market perspective
The global Full Blood Count (FBC) Test market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Full Blood Count (FBC) Test market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Full Blood Count (FBC) Test market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Full Blood Count (FBC) Test market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Full Blood Count (FBC) Test include one day tests, Labcorp OnDemand, Quest, Diag, Personalabs, Blue Horizon, Metropolis Healthcare, Hila and LabFinder, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Full Blood Count (FBC) Test market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Full Blood Count (FBC) Test.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Full Blood Count (FBC) Test Market by Company
one day tests
Labcorp OnDemand
Quest
Diag
Personalabs
Blue Horizon
Metropolis Healthcare
Hila
LabFinder
MAYO CLINIC
Better2Know
Medichecks
Vitall
Lab Me
Welzo
Full Blood Count (FBC) Test Segment by Type
Fingerstick Blood
Venous Blood
Full Blood Count (FBC) Test Segment by Application
Domestic
Commercial
Full Blood Count (FBC) Test Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Full Blood Count (FBC) Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Full Blood Count (FBC) Test and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Full Blood Count (FBC) Test.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Full Blood Count (FBC) Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Fingerstick Blood
- Venous Blood
Applications
- Domestic
- Commercial
Companies covered
- one day tests
- Labcorp OnDemand
- Quest
- Diag
- Personalabs
- Blue Horizon
- Metropolis Healthcare
- Hila
- LabFinder
- MAYO CLINIC
- Better2Know
- Medichecks
- Vitall
- Lab Me
- Welzo
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Full Blood Count (FBC) Test by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Fingerstick Blood
- 2.2.3 Venous Blood
- 2.3 Full Blood Count (FBC) Test by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Domestic
- 2.3.3 Commercial
- 2.4 Assumptions and Limitations
3 Full Blood Count (FBC) Test Breakdown Data by Type
- 3.1 Global Full Blood Count (FBC) Test Historic Market Size by Type (2021-2026)
- 3.2 Global Full Blood Count (FBC) Test Forecasted Market Size by Type (2027-2032)
4 Full Blood Count (FBC) Test Breakdown Data by Application
- 4.1 Global Full Blood Count (FBC) Test Historic Market Size by Application (2021-2026)
- 4.2 Global Full Blood Count (FBC) Test Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Full Blood Count (FBC) Test Market Perspective (2021-2032)
- 5.2 Global Full Blood Count (FBC) Test Growth Trends by Region
- 5.2.1 Global Full Blood Count (FBC) Test Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Full Blood Count (FBC) Test Historic Market Size by Region (2021-2026)
- 5.2.3 Full Blood Count (FBC) Test Forecasted Market Size by Region (2027-2032)
- 5.3 Full Blood Count (FBC) Test Market Dynamics
- 5.3.1 Full Blood Count (FBC) Test Industry Trends
- 5.3.2 Full Blood Count (FBC) Test Market Drivers
- 5.3.3 Full Blood Count (FBC) Test Market Challenges
- 5.3.4 Full Blood Count (FBC) Test Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Full Blood Count (FBC) Test Players by Revenue
- 6.1.1 Global Top Full Blood Count (FBC) Test Players by Revenue (2021-2026)
- 6.1.2 Global Full Blood Count (FBC) Test Revenue Market Share by Players (2021-2026)
- 6.2 Global Full Blood Count (FBC) Test Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Full Blood Count (FBC) Test Head Office and Area Served
- 6.4 Global Full Blood Count (FBC) Test Players, Product Type & Application
- 6.5 Global Full Blood Count (FBC) Test Manufacturers Established Date
- 6.6 Global Full Blood Count (FBC) Test Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Full Blood Count (FBC) Test Market Size (2021-2032)
- 7.2 North America Full Blood Count (FBC) Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Full Blood Count (FBC) Test Market Size by Country (2021-2026)
- 7.4 North America Full Blood Count (FBC) Test Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Full Blood Count (FBC) Test Market Size (2021-2032)
- 8.2 Europe Full Blood Count (FBC) Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Full Blood Count (FBC) Test Market Size by Country (2021-2026)
- 8.4 Europe Full Blood Count (FBC) Test Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Full Blood Count (FBC) Test Market Size (2021-2032)
- 9.2 Asia-Pacific Full Blood Count (FBC) Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Full Blood Count (FBC) Test Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Full Blood Count (FBC) Test Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Full Blood Count (FBC) Test Market Size (2021-2032)
- 10.2 South America Full Blood Count (FBC) Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Full Blood Count (FBC) Test Market Size by Country (2021-2026)
- 10.4 South America Full Blood Count (FBC) Test Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Full Blood Count (FBC) Test Market Size (2021-2032)
- 11.2 Middle East & Africa Full Blood Count (FBC) Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Full Blood Count (FBC) Test Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Full Blood Count (FBC) Test Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 one day tests
- 12.1.1 one day tests Company Information
- 12.1.2 one day tests Business Overview
- 12.1.3 one day tests Revenue in Full Blood Count (FBC) Test Business (2021-2026)
- 12.1.4 one day tests Full Blood Count (FBC) Test Product Portfolio
- 12.1.5 one day tests Recent Developments
- 12.2 Labcorp OnDemand
- 12.2.1 Labcorp OnDemand Company Information
- 12.2.2 Labcorp OnDemand Business Overview
- 12.2.3 Labcorp OnDemand Revenue in Full Blood Count (FBC) Test Business (2021-2026)
- 12.2.4 Labcorp OnDemand Full Blood Count (FBC) Test Product Portfolio
- 12.2.5 Labcorp OnDemand Recent Developments
- 12.3 Quest
- 12.3.1 Quest Company Information
- 12.3.2 Quest Business Overview
- 12.3.3 Quest Revenue in Full Blood Count (FBC) Test Business (2021-2026)
- 12.3.4 Quest Full Blood Count (FBC) Test Product Portfolio
- 12.3.5 Quest Recent Developments
- 12.4 Diag
- 12.4.1 Diag Company Information
- 12.4.2 Diag Business Overview
- 12.4.3 Diag Revenue in Full Blood Count (FBC) Test Business (2021-2026)
- 12.4.4 Diag Full Blood Count (FBC) Test Product Portfolio
- 12.4.5 Diag Recent Developments
- 12.5 Personalabs
- 12.5.1 Personalabs Company Information
- 12.5.2 Personalabs Business Overview
- 12.5.3 Personalabs Revenue in Full Blood Count (FBC) Test Business (2021-2026)
- 12.5.4 Personalabs Full Blood Count (FBC) Test Product Portfolio
- 12.5.5 Personalabs Recent Developments
- 12.6 Blue Horizon
- 12.6.1 Blue Horizon Company Information
- 12.6.2 Blue Horizon Business Overview
- 12.6.3 Blue Horizon Revenue in Full Blood Count (FBC) Test Business (2021-2026)
- 12.6.4 Blue Horizon Full Blood Count (FBC) Test Product Portfolio
- 12.6.5 Blue Horizon Recent Developments
- 12.7 Metropolis Healthcare
- 12.7.1 Metropolis Healthcare Company Information
- 12.7.2 Metropolis Healthcare Business Overview
- 12.7.3 Metropolis Healthcare Revenue in Full Blood Count (FBC) Test Business (2021-2026)
- 12.7.4 Metropolis Healthcare Full Blood Count (FBC) Test Product Portfolio
- 12.7.5 Metropolis Healthcare Recent Developments
- 12.8 Hila
- 12.8.1 Hila Company Information
- 12.8.2 Hila Business Overview
- 12.8.3 Hila Revenue in Full Blood Count (FBC) Test Business (2021-2026)
- 12.8.4 Hila Full Blood Count (FBC) Test Product Portfolio
- 12.8.5 Hila Recent Developments
- 12.9 LabFinder
- 12.9.1 LabFinder Company Information
- 12.9.2 LabFinder Business Overview
- 12.9.3 LabFinder Revenue in Full Blood Count (FBC) Test Business (2021-2026)
- 12.9.4 LabFinder Full Blood Count (FBC) Test Product Portfolio
- 12.9.5 LabFinder Recent Developments
- 12.10 MAYO CLINIC
- 12.10.1 MAYO CLINIC Company Information
- 12.10.2 MAYO CLINIC Business Overview
- 12.10.3 MAYO CLINIC Revenue in Full Blood Count (FBC) Test Business (2021-2026)
- 12.10.4 MAYO CLINIC Full Blood Count (FBC) Test Product Portfolio
- 12.10.5 MAYO CLINIC Recent Developments
- 12.11 Better2Know
- 12.11.1 Better2Know Company Information
- 12.11.2 Better2Know Business Overview
- 12.11.3 Better2Know Revenue in Full Blood Count (FBC) Test Business (2021-2026)
- 12.11.4 Better2Know Full Blood Count (FBC) Test Product Portfolio
- 12.11.5 Better2Know Recent Developments
- 12.12 Medichecks
- 12.12.1 Medichecks Company Information
- 12.12.2 Medichecks Business Overview
- 12.12.3 Medichecks Revenue in Full Blood Count (FBC) Test Business (2021-2026)
- 12.12.4 Medichecks Full Blood Count (FBC) Test Product Portfolio
- 12.12.5 Medichecks Recent Developments
- 12.13 Vitall
- 12.13.1 Vitall Company Information
- 12.13.2 Vitall Business Overview
- 12.13.3 Vitall Revenue in Full Blood Count (FBC) Test Business (2021-2026)
- 12.13.4 Vitall Full Blood Count (FBC) Test Product Portfolio
- 12.13.5 Vitall Recent Developments
- 12.14 Lab Me
- 12.14.1 Lab Me Company Information
- 12.14.2 Lab Me Business Overview
- 12.14.3 Lab Me Revenue in Full Blood Count (FBC) Test Business (2021-2026)
- 12.14.4 Lab Me Full Blood Count (FBC) Test Product Portfolio
- 12.14.5 Lab Me Recent Developments
- 12.15 Welzo
- 12.15.1 Welzo Company Information
- 12.15.2 Welzo Business Overview
- 12.15.3 Welzo Revenue in Full Blood Count (FBC) Test Business (2021-2026)
- 12.15.4 Welzo Full Blood Count (FBC) Test Product Portfolio
- 12.15.5 Welzo Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst